Summary The relation between the use of combination oral contraceptives (OCs) and the risk of epithelial ovarian cancer was investigated in a case-control study conducted in Milan on 209 women below the age of 60 with histologically confirmed epithelial ovarian cancer, and 418 age-matched controls with a spectrum of acute conditions apparently unrelated to OC use. Combination oral contraceptives were used by 18 (9%) cases, and 59 (14%) controls, giving a relative risk estimate of 0.6 (95% confidence interval=0.3-1.0, P<0.05). The risk of ovarian cancer decreased with increasing duration of use and the point estimate remained below unity long after cessation of use. These results were not accounted for by parity, infertility, or other identified potential confounding factors. Thus, the findings of the present study add further support to the evidence emerging from American data of a reduction of -40% in the risk of epithelial ovarian cancer among women who had used oral contraceptives.
Evidence from several case-control studies conducted mainly in North America (McGowan et al., 1979; Annegers et al., 1979; Hildreth et al., 1981; Weiss et al., 1981; Willett et al., 1981; Rosenberg et al., 1982; Cramer et al., 1982; Casagrande et al., 1983 ; Centers for Disease Control Cancer and Steroid Hormone Study, 1983 ; see also Newhouse et al., 1977) suggests that the use of cQmbined oral contraceptives (OCs) reduces the risk of epthelial ovarian cancer. General lifestyle and reproductive characteristics, however, are notoriously different in Italy. Oral contraceptive use, in particular, is less common and usually concentrated in the younger age groups. It is, therefore, of interest to re-evaluate the relation of OC use to the risk of ovarian cancer in such a population. This has been done in the present study, using data from a case-control study conducted in Milan.
Subjects and methods
Since 1979, we have conducted a case-control study of ovarian cancer (Franceschi et al., 1982) . Trained interviewers identify and question women admitted for ovarian cancer and for a wide spectrum of other conditions to University and General Hospitals in the Greater Milan area. On the average, <2% of the eligible women (cases or controls) refuse to be interviewed.
A standard questionnaire is used to obtain information on personal characteristics and habits, gynaecological and obstetric data, related medical history and history of lifetime use of oral contraceptives and other female hormones. The present study is based on data obtained before September 30, 1983.
Cases
The cases studied were women with histologically confirmed epithelial ovarian cancer, diagnosed within the year prior to interview, admitted to the First Obstetrics and Gynaecology Clinic of the University and to the National Cancer Institute of Milan. There were 209 women younger than 60 years who met these criteria. The histological type was serous carcinoma in 61%, endometrioid carcinoma in 13%, mucinous carcinoma in 13%, clear cell carcinoma in 6%, and undifferentiated carcinoma in 7%.
Controls
Potential controls were all women below the age of 60 years whose primary diagnosis was judged to be unrelated to any of the established or suspected risk factors for ovarian cancer. Women were not eligible if they were admitted for gynaecological, hormonal or neoplastic diseases, or had undergone bilateral oophorectomy. The pool of potential controls was reduced by selecting at random two controls per case from the same 5-year age group. Of the final control series (418 patients) 45% had musculoskeletal diseases (trauma or other orthopaedic conditions), 23% were admitted for acute abdominal disorders that generally required operations, and 32% had other illnesses, such as ear, nose and throat, or teeth disorders.
Data analysis
We estimated the odds ratios (as estimators of the relative risk, RR; Fleiss, 1981) of ovarian cancer, together with their 95% approximate confidence intervals (CI) (Miettinen, 1976) among women who used oral contraceptives relative to women who had never used them. The significance of the linear trend in the risk according to the duration of use was assessed using the test given by Mantel (1963) . Nulliparity, late age at first birth and later menopause were more frequent among the cases than the controls. These and other (see belowvariables included in the regression) potential confounding factors were first controlled individually using stratification and the MantelHaenszel procedure (Mantel & Haenszel, 1959) ; secondly, they were simultaneously controlled by means of multiple logistic regression, fitted by the method of maximum likelihood (Breslow & Day, 1980 The decreased risk of ovarian cancer among ever users was consistent across strata of age, parity and gravidity (data not shown, as similar to parity) and age at first birth (Table III) . The protection, however, was apparently confined to women who had used the pill after first full term pregnancy with a risk estimate of 0.2, while the relative risk was 1.0 for OC use before first birth (Table IV) . These two estimates, nonetheless, were not significantly different, as their confidence intervals overlapped. Oral contraceptive use was compared within strata of marital status, education, cigarette smoking, menopausal status and age at menopause. There was no indication that the protection was confined to any particular sub-group. Likewise, the results were practically unchanged when a large number of factors were taken into account by means of multiple logistic regression. Moreover, to assess the potential confounding effect of infertility or sub- (La Vecchia et al., 1983) . This topic, therefore,. is of potential interest, and warrants further analysis.
In conclusion, the findings of the present study add further support to the evidence, emerging mainly from American data (McGowan et al., 1979; Annegers et al., 1979; Hildreth et al., 1981; Weiss et al., 1981; Willett et al., 1981; Rosenberg et al., 1982; Cramer et al., 1982; Casagrande et al., 1983 ; Centers for Disease Control Cancer and Steroid Hormone Study, 1983) , of a reduction of -40% in the risk of epithelial ovarian cancer among women who had used oral contraceptives. This result is statistically significant, even with a considerably lower proportion of ever users (15% in the comparison group of this series versus 30-60% in American series of comparable age, Rosenberg et al., 1982; Centers for Disease Control Cancer and Steroid Hormone Study, 1983) , and with a shorter average duration of use. Oral contraceptive use, moreover, was essentially concentrated in the younger age groups, but the protective effect was evident for all the subsequent age strata considered.
As a biological correlate of this epidemiological finding, it has been suggested that oral contraceptives might confer protection against ovarian cancer simply by inhibiting ovulation. A few criticisms, however, have been made to the model which relates the risk of ovarian cancer to the simple duration of ovulatory activity, mainly based on the different effect of the first term pregnancy at different ages, age at first birth being apparently more strongly associated with the risk of ovarian cancer than the actual number of births (La Vecchia et al., 1983) . Alternatively, the reduction of pituitary gonadotropin secretion (which reportedly stimulates growth of cell lines derived from human ovarian carcinomas, Simon et al., 1983 ) might well explain the negative association between combination oral contraceptives and the risk of ovarian cancer.
